Rafael Pharmaceuticals' Series B - IV Round

Rafael Pharmaceuticals raised a round of funding on January 18, 2010. Investors include Althea Partners.

Rafael Pharmaceuticals, formerly Cornerstone Pharmaceuticals, is a privately held, clinical-stage, oncology-focused, pharmaceutical company committed to the development and commercialization of therap…

Articles about Rafael Pharmaceuticals' Series B - IV Round: